期刊文献+

新鲜冰冻血浆随中心温度变化其活性成分含量的研究 被引量:2

A Study on the Content of Active Components in Fresh Frozen Plasma Varying with Central Temperature
下载PDF
导出
摘要 目的通过测定新鲜冰冻血浆解冻过程的中心温度,研究以中心温度作为解冻终止控制因素对于血液中活性成分的影响。方法通过固定于血浆中心位置的温度探头实现对血浆中心温度的监测和记录;同一袋血浆解冻过程达到不同的中心温度进行连续取样测定不稳定凝血因子Ⅴ、因子Ⅷ及纤维蛋白原(FIB)。结果不稳定的凝血因子Ⅴ、因子Ⅷ及FIB在新鲜冰冻血浆中心温度4℃至33℃之间保持稳定且较高水平,随解冻时间延长其水平下降。结论血浆完全解冻后,需要尽快取出以减少不稳定凝血因子Ⅴ、因子Ⅷ及纤维蛋白原(FIB)的消耗,保证新鲜冰冻血浆的质量,提高临床输注效果。 Objective By measuring the central temperature of fresh frozen plasma during the thawing process,the influence of central temperature as the control factor of thawing termination on active ingredients in blood was studied.Methods The plasma central temperature was monitored and recorded by a temperature probe fixed at the central position of the plasma.The same bag of plasma was thawed at different central temperatures through continuous sampling to determine levels of unstable coagulation factor V,factor VIII and fibrinogen(FIB).Results The levels of unstable coagulation factor V,factor VIII and FIB remained stable and were kept high between 4℃and 33℃in fresh frozen plasma,and their levels decreased with the extension of thawing duration.Conclusion After the plasma is completely thawed,it should be taken out as soon as possible to reduce the consumption of unstable coagulation factor V,factor VIII and fibrinogen(FIB),to ensure the quality of fresh frozen plasma and improve the clinical infusion effect.
作者 崔若帅 刘洋 关晓珍 汪德清 康熙雄 CUI Ruoshuai;LIU Yang;GUAN Xiaozhen;WANG Deqing;KANG Xixiong(Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing 100050, China;Department of Blood Transfusion, the First Medical Center of PLA General Hospital, Beijing 100853,China)
出处 《标记免疫分析与临床》 CAS 2020年第11期1982-1985,共4页 Labeled Immunoassays and Clinical Medicine
基金 解放军总医院临床科研扶持基金项目“战创伤凝血制品冷沉淀制备条件优化研究”(编号:2018FC-WJFWZX-1-18)。
关键词 中心温度 新鲜冰冻血浆 凝血因子 Central temperature Fresh frozen plasma Coagulation factor
  • 相关文献

参考文献7

二级参考文献38

  • 1黄海燕.新鲜冰冻血浆融化后不同放置时间凝血因子的变化[J].中国现代药物应用,2009,3(3):21-22. 被引量:8
  • 2黄毅,王憬惺.血液细胞成分病原体灭活技术及效果评价[J].中国输血杂志,2004,17(3):206-210. 被引量:8
  • 3杨江存,李芒会,于青,董选玲,曾晓华,任健康.新鲜冰冻血浆融化后不同放置时间凝血因子的变化[J].中国输血杂志,2005,18(3):211-212. 被引量:49
  • 4杨天楹.临床输血学[M].北京:北京医科大学中国协和医科大学联合出版社,1999.144-414.
  • 5杨江存,李芒会.新鲜冰冻血浆融化后不同放置时间凝血因子的变化[J].临床血液学杂志,2004,(1):14-15.
  • 6焦向杰.血液与输血[M].北京:中国科学技术出版社,1993.203.
  • 7Politis C, Kavallierou L, Hantziara S, et al. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience[J]. Transfusion,2007, 47(2) : 319--326
  • 8Wagner SJ, Cifone MA, Murli H, et al. Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation [J]. Transfusion, 1995, 35(4) :407--415
  • 9Singh Y, Sawyer LS, Pinkoski LS, et al. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function[J]. Transfusion,2006, 46(7) : 1168-- 1177
  • 10Ciaravino V, McCullough T, Cimino G, et al. Preclinieal safety profile of plasma prepared using the INTERCEPT Blood System[J]. Vox Sang,2003, 85(3):171-182

共引文献80

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部